Cumberland`s to expand availability of Vibativ to treat hospital-acquired & VAP
24 Mar 2020 //
PHARMABIZ
Cumberland Pharma Announces Initiative To Expand Availability Of VIBATIV®
23 Mar 2020 //
PR NEWSWIRE
Cumberland `s To Hold Update Call To Discuss Recent Major Developments
03 Jan 2020 //
PR NEWSWIRE
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex™ Product Line
02 Dec 2019 //
PR NEWSWIRE
Cumberland Signs Exclusive Licensing Agreement For Distribution In China
15 May 2019 //
PR NEWSWIRE
Cumberland Pharmaceuticals Announces Strategic Review
29 Mar 2019 //
PR NEWSWIRE
Cumberland Pharmaceuticals Appoints New Senior Executive
07 May 2018 //
PR NEWSWIRE
Savara Pharmaceuticals Appoints David L. Lowrance As CFO
02 Nov 2016 //
PR NEWSWIRE
Cumberland Pharmaceuticals Announces New Program To Develop Portaban
14 Sep 2016 //
PR NEWSWIRE
Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol
23 Aug 2016 //
PR NEWSWIRE
Cumberland Pharmaceuticals Announces C. Young To Join Its Board Of Directors
10 Jun 2016 //
PR NEWSWIRE
Cumberland Pharma & Clinigen Group enter into exclusive US commercial agreement
10 May 2016 //
PR NEWSWIRE
Cumberland Pharmaceuticals unveils new program to develop Vasculan
27 Apr 2016 //
PBR
Caldolor Approved For Use In Pediatric Patients
23 Nov 2015 //
PR NEWSWIRE
Cumberland Pharmaceuticals Announces Favorable Acetadote® Patent Ruling
20 Nov 2015 //
PR NEWS WIRE
Clinigen and Cumberland collaborate in mutual market access deal
17 Sep 2015 //
IN-PHARMA TECHNOLOGIST